Amkay Products Ltd
AMKAYBSE
₹58.00▲ +0.00 (+0.00%)
Whole company worth₹50 Cr
Price for ₹1 of profit₹22
1-year range₹43 – ₹82
The short version
A slow-growing, thinly profitable business — priced richly for what it earns.
What Amkay Products does
Incorporated in 2007, Amkay Products Ltd manufactures personalized healthcare products
Worked out from Amkay Products's own filed results and exchange data, in plain words. Where a finance term matters, we say what it means.
01What does it do?
Amkay Products is a micro-sized company in medical equipment.
Incorporated in 2007, Amkay Products Ltd manufactures personalized healthcare products
- Whole company is worth
- ₹50 crore
- Run by
- Kashyap Pravin Mody
- Shareholders
- 361 people
- Listed since
- 2024
A very small company by stock-market value — prices can swing hard and trading can be thin.
02Is it growing?
Sales have grown 1% a year for 5 years.
Profit, though, fell 4% a year over the same stretch.
Point at a bar for exact figures · amounts in ₹ crore
03Does it make money?
Out of every ₹100 it sells, it keeps ₹5.5 as profit.
Here is where the money from Amkay Products's sales went in FY26, the latest full year it has reported.
₹67
₹22
- ₹67Making or buying what it sellsraw materials, stock, goods bought for resale
- ₹22Running the businessstaff, rent, marketing, power and everything else
- ₹1.0Interest on its loansthe cost of borrowed money
- ₹2.1Wear and tearmachines, stores and buildings losing value over time
- ₹2.1Taxincome tax paid to the government
- ₹5.5Profit it keepswhat is left for the company's owners
On the money its owners have put in
It earns ₹9 a year on every ₹100 its owners have invested.
Bank FD ~₹6–7
₹9
₹0₹10₹20₹30₹40
That figure is called return on equity (ROE). Under ₹12 is a thin return for the risk of owning shares. For comparison, a bank fixed deposit pays roughly ₹6–7.
Does the profit turn into cash?
For every ₹100 of profit it reported, ₹2 actually came in as cash.
Profit it reported₹8.3 Cr
Cash its business brought in₹0.2 Cr
Over the last 3 years: ₹8.3 crore of profit but only ₹0.2 crore of cash. A wide gap like this is worth understanding before trusting the profit figure.
04Is the price high or low?
You pay ₹22 for every ₹1 of profit it makes in a year.
This is the P/E ratio: share price divided by a year's profit per share. A P/E of 22 means buyers are paying for about 22 years of today's profit up front.
The share price over the past year
It is 29% below its highest price of the past year and 35% above its lowest.
05Who owns it?
Its founders and parent group own 73 of every 100 shares — they control the company.
If the company were split into 100 equal shares, this is who would hold them. 361 people and institutions hold its shares.
As filed for the quarter ending 30 Sept 2026. Arrows show the change since the quarter before, in percentage points.
06What is going well, and what to watch
The figures raise more questions than they answer.
Picked out of the numbers above by fixed rules — the same rules for every company — so nothing here is somebody's opinion.
Going well
Nothing stands out in its favour in the figures we have.
Worth watching
- Thinly traded — only about ₹7 lakh of shares change hands a day, so buying or selling can move the price.
07What happened lately?
Its latest quarter.
Jan–Mar 2026 is the most recent quarter it has reported. Each figure is compared with the same three months a year earlier, because many businesses sell more in some seasons than others.
Sales
₹19 Cr
Profit
₹0.3 Cr
No notable developments in the last few weeks.
Advanced view
Every number, every table, the full chart.
Ten years of statements, quarterly results, peers side by side, technical indicators, analyst estimates, bulk deals and filings.
Ask DoXy
Still have a question about Amkay Products?
This page describes Amkay Products using its reported figures and exchange data. It is for information only and is not investment advice or a recommendation to buy, sell or hold. DocStoX is not a SEBI-registered investment adviser or research analyst.
Amkay Products Ltd (AMKAY): company summary
The company's annual revenue rose 9.5% to ₹42 crore, but annual net profit fell 30.8% to ₹2 crore.
Amkay Products Ltd (AMKAY) is a micro-cap Healthcare company valued at ₹50 crore operating in Medical Equipment on the NSE and BSE.
- Recent price move
- Amkay Products Ltd last traded at ₹58, unchanged on the day.
- Financial performance
- The company's annual revenue rose 9.5% to ₹42 crore, but annual net profit fell 30.8% to ₹2 crore. The latest quarter saw revenue drop 7.4% year-on-year to ₹19 crore, while net profit fell 77.5% to ₹0 crore.
- Valuation multiples
- The stock trades at 21.7 times earnings, a discount to the Healthcare median of 32.0, 1.69 times book value.
- Things to watch
- The company's net profit margin narrowed 3.2 percentage points to 5.5%. The latest quarter net profit fell 77.5% to ₹0 crore. The stock is 29.3% below its 52-week high.
- Where it stands
- The company's annual revenue grew 9.5% to ₹42 crore, but net profit declined 30.8% to ₹2 crore. The latest quarter net profit fell 77.5% to ₹0 crore, while the stock is 29.3% below its 52-week high.
Summarised by DocStoX's model on 2026-10-18 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
More Healthcare stocks · Medical Equipment
Explore Amkay Products Ltd’s valuation
Free deep-dive tools · no sign-up
Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.
Amkay Products Ltd peers in Healthcare
Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.
Sun Pharmaceutical Industries LimitedDivi's Laboratories LimitedTorrent Pharmaceuticals LimitedLaurus Labs LimitedZydus Lifesciences LimitedApollo Hospitals Enterprise LimitedCipla LimitedDr. Reddy's Laboratories LimitedMankind Pharma LimitedAurobindo Pharma LimitedLupin LimitedManipal Health Enterprises Limited
Compare Amkay Products Ltd with peers
Amkay Products Ltd vs Sun Pharmaceutical Industries LimitedAmkay Products Ltd vs Divi's Laboratories LimitedAmkay Products Ltd vs Torrent Pharmaceuticals LimitedAmkay Products Ltd vs Laurus Labs LimitedAmkay Products Ltd vs Zydus Lifesciences LimitedAmkay Products Ltd vs Apollo Hospitals Enterprise Limited
Related tools & concepts
Value Amkay Products Ltd with the ratios and calculators DocStoX uses in its analysis.
P/E RatioPrice to earningsReturn on Equity (ROE)ProfitabilityROCECapital efficiencyDebt to EquityLeverageP/B RatioPrice to bookNet Profit MarginBottom-line efficiencyDCF / Intrinsic ValueEstimate fair valueCAGR CalculatorAnnualised returnDividend YieldIncome on pricePosition SizeRisk-based sizingBrokerage CalculatorCharges on a tradeSIP CalculatorSystematic investing